GlassScriptPhysician profile
Hala S Nahhas
NPI 1588860639
$3,016.15
in general payments reported to CMS, 2019-2025
34 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.50 · 2020: $74.79 · 2024: $1,127 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,927.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $340.74 | 2024-2025 | |
| Ucb, INC. | $294.02 | 2024-2025 | Nayzilam, Briviact, Rystiggo |
| Alexion Pharmaceuticals, INC. | $199.07 | 2024-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $167.82 | 2020-2025 | Austedo Xr, Ajovy |
| Tg Therapeutics, INC. | $159.75 | 2025 | |
| Neurocrine Biosciences, INC. | $153.18 | 2024-2025 | Ingrezza |
| Lundbeck LLC | $149.36 | 2024-2025 | Vyepti, Rexulti |
| Eisai INC. | $147.25 | 2025 | |
| Catalyst Pharmaceuticals, INC. | $138.57 | 2024-2025 | |
| Argenx US, INC. | $126.67 | 2024-2025 | Vyvgart Hytrulo |
| Pfizer INC. | $118.54 | 2024-2025 | |
| Celgene Corporation | $110.39 | 2024-2025 | Zeposia |
| Abbvie INC. | $103.53 | 2024-2025 | |
| Biogen, INC. | $84.61 | 2024-2025 | Tysabri, Vumerity, Avonex |
| Vanda Pharmaceuticals INC. | $84.05 | 2025 | Ponvory |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $84.00 | 2025 | Hizentra |
| Genentech USA, INC. | $73.53 | 2024-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Lilly USA, LLC | $68.93 | 2020-2024 | Kisunla |
| Otsuka America Pharmaceutical, INC. | $52.97 | 2024-2025 | Rexulti |
| Tanabe Pharma America, INC. | $49.76 | 2025 | Radicava |
| Alnylam Pharmaceuticals INC. | $36.96 | 2024-2025 | Onpattro |
| Takeda Pharmaceuticals U.S.A., INC. | $36.51 | 2024 | Hyqvia |
| Emd Serono, INC. | $30.12 | 2019-2024 | |
| Axsome Therapeutics, INC. | $25.08 | 2025 | Symbravo |
| Cycle Pharmaceuticals INC | $22.93 | 2025 | Tascenso Odt |
| Sumitomo Pharma America, INC. | $22.42 | 2024 | Aptiom |
| Janssen Biotech, INC. | $20.78 | 2024 | Rybrevant |
| Pharmacosmos Therapeutics INC. | $18.60 | 2025 | Monoferric |
| Astrazeneca Pharmaceuticals LP | $17.70 | 2024 | Andexxa |
| Neurelis, INC. | $17.49 | 2024 | Valtoco |
| Stemline Therapeutics INC. | $17.20 | 2024 | Orserdu |
| Mdd US Operations, LLC | $16.81 | 2020 | |
| Azurity Pharmaceuticals, INC. | $16.53 | 2024 | Horizant |
| Janssen Pharmaceuticals, INC | $10.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hala Nahhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.